2023 Chinese Congress of Radiology

We transform medical images into meaningful, actionable insights to help better diagnose, treat, and monitor patients. We deploy proprietary artificial intelligence, computer vision, and signal processing technologies to develop imaging tests and services, addressing life-threatening unmet medical needs.

With eyonis™ we are disrupting the management of serious diseases such as lung cancer and liver cancer. We are deploying AI/ML Software as Medical Devices (SaMDs) to help health professionals diagnose patients earlier, treat them more effectively, and bring new hope. eyonis™ is currently under development.

Imaging Services for Clinical Trials

Median’s Imaging CRO business provides leading oncology clinical trial imaging services, empowering our life sciences partners to accelerate the development and delivery of life-saving cancer treatments with unmatched operational excellence and reliability. And we don’t stop there. We are forging the way when it comes to innovative imaging technology, leveraging the latest in AI-powered imaging intelligence to develop actionable insights for biopharma sponsors worldwide.

Learn More

Request a Demo

The purpose of this conference is to fully demonstrate the overall level and characteristics of radiology in China and strive to improve the academic status and international influence of medical imaging in China.

Meet Median iCRO team in Suzhou to discuss how we provide best-in-class imaging solutions for oncology clinical trials with our broad network of independent readers around the world and how we are collaborating with radiologists to leverage the latest in AI-powered imaging intelligence to develop actionable insights for oncology clinical trials. We will be happy to meet you at booth A63.